About DxGen
DxGen is a company founded in 2016.. DxGen offers products and services including Epithod® 616 Analyzer, HbA1c Test Kit, CRP Test Kit, AUTODX, and MINI BIOSCIENCE. DxGen operates in a competitive market with competitors including SD Biosensor, Access Bio, Lumos Diagnostics, 1Drop Diagnostics and Fluxergy, among others.
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name (주)딕스젠 Dxgen Corp
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DxGen
DxGen offers a comprehensive portfolio of products and services, including Epithod® 616 Analyzer, HbA1c Test Kit, CRP Test Kit, AUTODX, and MINI BIOSCIENCE. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Reliable system for diabetes and infectious disease testing.
Determines Glycated Hemoglobin levels in human blood.
Measures C-reactive protein in blood for diagnostics.
System for HbA1c and other biomarker testing.
Provides tools for biomarker analysis and diagnostics.
Funding Insights of DxGen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by DxGen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - DxGen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dxgen Comparisons
Competitors of DxGen
DxGen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SD Biosensor, Access Bio, Lumos Diagnostics, 1Drop Diagnostics and Fluxergy, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
|
|
| domain | founded_year | HQ Location |
In vitro rapid diagnostic tests, biosensor, and molecular diagnostic products for diagnosis of infectious diseases.
|
|
| domain | founded_year | HQ Location |
Diversified diagnostic assays and readers are developed for point-of-care use.
|
|
| domain | founded_year | HQ Location |
Finger-prick point-of-care diagnostics are provided for biomarker testing.
|
|
| domain | founded_year | HQ Location |
Provides diagnostic devices and software for clinical and veterinary point-of-care testing.
|
|
| domain | founded_year | HQ Location |
Point-of-care tests for diabetes and women's health risks are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Dxgen
Frequently Asked Questions about DxGen
When was DxGen founded?
DxGen was founded in 2016.
What does DxGen do?
DxGen was founded in 2016 and operates in the healthcare diagnostics sector. Point-of-care analyzers and test kits are supplied for diabetes management, covering stages from initial assessment to post-diagnosis treatment. Measurements include HbA1c, glycated albumin, CRP, hemoglobin, micro-albumin, and tuberculosis markers. Multi-marker diagnostic devices for diabetes and tuberculosis patients are under development.
Who are the top competitors of DxGen?
DxGen's top competitors include Access Bio, SD Biosensor and Lumos Diagnostics.
What products or services does DxGen offer?
DxGen offers Epithod® 616 Analyzer, HbA1c Test Kit, CRP Test Kit, AUTODX, and MINI BIOSCIENCE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.